Filing Details

Accession Number:
0001209191-23-004501
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-23 19:00:21
Reporting Period:
2023-01-19
Accepted Time:
2023-01-23 19:00:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1754068 Allovir Inc. ALVR () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1619252 Edward Miller C/O Allovir, Inc.
1100 Winter Street
Waltham MA 02451
General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-12-02 98,346 $0.00 151,031 No 5 G Direct
Common Stock Acquisiton 2022-12-02 98,346 $0.00 288,799 No 5 G Indirect See footnote
Common Stock Disposition 2023-01-19 2,032 $5.08 148,999 No 4 S Direct
Common Stock Disposition 2023-01-20 541 $5.14 148,458 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 G Direct
No 5 G Indirect See footnote
No 4 S Direct
No 4 S Direct
Footnotes
  1. On December 2, 2022, the Reporting Person transferred 98,346 shares to The Miller Family 2019 Irrevocable Dynasty Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  2. Shares held by The Miller Family 2019 Irrevocable Dynasty Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  3. Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and intended to qualify under Rule 10b5-1.
  4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.94 to $5.19. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.05 to $5.22. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.